To the full analysis
Buyback calculator for Editas Medicine
Editas Medicine stock: key metrics
EDITEditas Medicine had an operating margin of −245.2% and a return on invested capital (ROIC) of −37.8% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2013 | no data | no data | no data |
| 2014 | no data | no data | no data |
| 2015 | −1,056.9% | −2,167.7% | −4,475.1% |
| 2016 | −841.3% | −1,605.6% | −1,605.5% |
| 2017 | −505.8% | −873.6% | −876.5% |
| 2018 | −183.9% | −356.1% | −344.3% |
| 2019 | −372.0% | −686.4% | −651.4% |
| 2020 | −74.1% | −148.6% | −127.8% |
| 2021 | 80.2% | −756.1% | −753.6% |
| 2022 | 67.9% | −1,146.3% | −1,118.3% |
| 2023 | 92.2% | −216.6% | −196.1% |
| 2024 | −516.6% | −777.2% | −733.7% |
| 2025 | 100.0% | −245.2% | −395.0% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2013 | 200.0% | no data | −100.0% |
| 2014 | 89.5% | no data | −100.0% |
| 2015 | 87.7% | −37.6% | −48.8% |
| 2016 | −72.2% | −44.1% | −42.4% |
| 2017 | −57.8% | −34.4% | −32.2% |
| 2018 | −46.6% | −24.7% | −26.2% |
| 2019 | −51.0% | −26.7% | −26.3% |
| 2020 | −29.5% | −22.1% | −20.3% |
| 2021 | −34.8% | −26.7% | −28.4% |
| 2022 | −61.1% | −32.9% | −42.9% |
| 2023 | −43.9% | −29.6% | −30.7% |
| 2024 | −100.0% | −55.7% | −69.4% |
| 2025 | −100.0% | −37.8% | −85.8% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 28 Feb 2018)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.